Abstract. Neutrophil adherence to cytokine-activated endothelial cell (EC) monolayers depends on the expression of the endothelial leukocyte adhesion molecule-1 (ELAM-1). The ligand for ELAM-1 is the sialylated Lewis-x antigen (SLe0 structure. The selectin LAM-1 (or LECAM-1) has been described as one of the SLex-presenting glycoproteins involved in neutrophil binding to ELAM-1. Other presenter molecules have not yet been described.
were tested as well. PNH neutrophils showed a diminished binding to activated EC. CD66 (on PNH cells still recognizing the transmembrane NCA-160 form) still inhibited the adherence of PNH cells to IL-1-Bactivated EC, but to a limited extent.
Soluble CEA(-related) antigens inhibited normal neutrophil adherence as well, whereas neutrophil transmigration was unaffected. Sialidase-treatment as well as CD66 preclearing abolished the inhibitory capacity of the CEA(-related) antigens. The binding of soluble CEA antigens to IL-1-B-pretreated EC was blocked by anti-ELAM-1. These soluble antigens, as well as the neutrophil NCA-160 and NCA-90, both recognized by CD66 antibodies, presented the SLe x determinant.
Together, these findings indicate that the CD66 antigens (i.e., NCA-160/NCA-90) function as presenter molecules of the SLe x oligosaccharide structures on neutrophils that bind to ELAM-1 on EC.
M
IGRATION of neutrophils from the bloodstream to inflammatory sites requires the expression of the CD18 integrin subfamily (LFA-1, CR3, and p150,95) (Harlan, 1985; Anderson et al., 1985; Kuijpers and Roos, 1989; Springer, 1990) . In the neutrophil adherence to the vascular lining, endothelial ICAM-1 may function as a cellular ligand for LFA-1 and CR3 (Rothlein et al., 1986; Diamond et al., 1990) . The accessory role of the human selectin family (endothelial leukocyte adhesion molecule 1 [ELAM-1], t GMP-140, and LAM-1) (Bevilacqua et al., 1989; Johnston et al., 1989; Tedder et al., 1989 ) is well documented.
Unless activated, the endothelial cells do not express the selectin members. Upon activation of endothelial cells (EC)
1. Abbreviations used in this paper: CEA, carcinoembryonic antigen; EC, endothelial cells; ELAM-1, endothelial leukocyte adhesion molecule 1; FMLE formyl-methionyl-leucyl-phenylalanine; HSA, human serum albumin; IL-1, interleukin-1; Le x, Lewis-x antigen; NCA, nonspecific crossreacting antigen; PI, phosphatidylinositol; PNH, paroxysmal nocturnal hemoglobinuria; r, recombinant; SLe x, sialylated Lewis-x antigen. with thrombin or histamine, GMP-140 is momentarily upregulated by fusion of intracellular Weibel-Palade bodies with the plasma membrane (Bonfanti et al., 1989; Hattori et al., 1989) . In contrast, ELAM-1 expression depends on de novo synthesis, and is induced by the inflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor (TNF). Its expression is transient with a peak at 4-6 h (Bevilacqua et al., 1987; Luscinskas et al., 1989) . Recent evidence suggests a role for LAM-1 on neutrophils in the recruitment to inflammatory lesions (Watson et al., 1991; Smith et al., 1991) .
The ligands recognized by ELAM-1 and GMP-140 are similar but not necessarily identical (Zhou et al., 1991; Berg et al., 1991) . Sialidase treatment of neutrophils abolishes binding to either of the two selectins. Moreover, antibodies directed to the sialylated Lewis-x antigen (SLe0 (Lowe et al., 1990; Goelz et al., 1990; Phillips et al., 1990; Walz et al., 1990 ) block both interactions (Polley et al., 1991) . Unrelated to these sialylated ligands, a group of sulfated galactosyl ceramides (sulfatides) have been discovered as func-tional ligands for GMP-140 (but not ELAM4) (Aruffo et al., 1991) .
The selectin member LAM-1 was reported to be involved in the neutrophil adherence to ELAM-1 Picker et al., 1991) . Although LAM-1 on neutrophils bears SLe x, its role as the predominant presenter of critical oligosaccharide determinants must be limited to the initial phase of adherence: LAMA-negative neutrophils still bind to ELAM-1 . Thus, other SLe x oligosaccharide presenters must exist on the neutrophil surface.
For several reasons carcinoembryonic antigen (CEA)-related molecules are of potential importance in the ELAM-1 interactions: (a) colon carcinoma cell lines expressing CEA bind to cytokine-activated EC (Dejana et al., 1988; Benjamin et al., 1990) ; (b) The CEA(-like) antigens possess adhesive properties (Oikawa et al., 1989; Benchimol et al., 1989) ; (c) neutrophils express several CEA(-like) nonspecific cross-reacting antigens (NCAs) (Buchegger et al., 1984; Audette et al., 1987; Kuroki et al., 1990) with >80% homology between CEA and NCAs (Thompson et al., 1987) ; and (d) CEA(-like) antigens are highly glycosylated molecules with multiple sialyl and fucosyl residues (Kobata et al., 1989; Thomas et al., 1990) . The CEA family is a group of proteins that belongs to the immunoglobulin supergene family (Williams and Barclay, 1988) .
In our hands, three different CEA-like surface antigens can be distinguished on neutrophils by immunoprecipitation and Western blotting techniques. The CD66 and CD67 mAb directed to granulocyte-specific antigens (Majdic, 1989; Stockinger, 1989; Van der Schoot et al., 1989a,b) have recently been identified to bind to the antigens NCA-160, NCA-95, and NCA-90 (Van der Schoot et al., 1989a, 1990; Watt et al., 1991) . NCA-160 (binding CD66) is a transmembrane phosphoprotein (Van der Schoot et al., 1989a) , NCA-95 (binding CD67) and NCA-90 (binding CD66) are strictly phosphatidylinositol (PI)-linked surface proteins (Van der Schoot et al., 1989b; Kolbinger et al., 1989; Hefta et al., 1990; Berling et al., 1990) .
In this paper, we describe the role of the membraneintercalated NCA proteins in neutrophil adherence to and transmigration across cytokine-treated EC. The functional importance of these proteins is corroborated by the ability of soluble CEA to specifically inhibit these neutrophil interactions.
Materials and Methods

Reagents
Formyl-methionyMeucyl-phenylalanine (FMLP), PMA, protein A-Sepharose, cyanogen bromide-activated Sopharose, and dimethyl pimelidate were purchased from Sigma Chem. Co. (St. Louis, Me). FMLP and PMA were dissolved in DMSO at 1,000x the final concentration for cell stimulation, and were stored at -20~ The rabbit anti-human CEA serum was obtained from Dakopats (Glostrup, Denmark). Purified CEA product (prepared from PCA extracts of liver metastasis of human colonic adenocarcinoma) was purchased from Zymed Labs. Inc. (South San Francisco, CA). The following purified murine mAbs OgG1) were used: Nee-618, 26/3/13, 4/3/17, CD66 CLB-granl0 (IH4), 49.30, CD67 CLB-B13.9, MUS, 80H3, and N1 (Table I) (Berling et al., 1990; Tetteroo et al., 1986) . Nee-618 and 49.30 were purchased from Sanbyo (Uden, The Netherlands) and 80H3 from l)ianova (Hamburg, Germany). (None of the anti-CEA/NCA mAbs used in the present study induced any neutrophil activation measured as NADPH oxidase activity, neutrophil aggregation, change in intracellular Ca 2+ or cAMP level [not shown]). In additional experiments, the CD15 mAb CLB-B4.3 (IgM) (Tetteroo et al., 1984) or CSLEX-1 (IgM) (Fukushima et al., 1984) to SLe x were used as indicated. CSLEX-1 was provided by Dr. Paul Terasaki (University of California Medical School, Los Angeles, CA). In control experiments CD18 mAb CLB-LFAI/1 (Miedema et al., 1984) or anti-ELAM-I mAb ENA-2 (Laeuwenberg et al., 1989) F(ab)2 fragments were used as described before . The basal incubation medium for cell suspensions consisted of a 1:1 mixture of RPMI-1640 and Medium 199 (Gibco Laboratories, Paisley, UK), supplemented with 0.5% (wt/vol) human serum albumin (HSA).
Granulocyte Isolation
Granulocytes from healthy controls or patients suffering from paroxysmal nocturnal hemoglobinuria (PNH) were purified from 30-50 ml of whole blood anticoagulated with 0.4% (wt/vol) trisodium citrate (pH 7.4), essentially as described (Roos and de Boer, 1986) . After density gradient eentrifugation over isotonic Percoll (1.076 g/ml), the interphase containing the mononuclear ceils was removed, and erythrocytes were lysed by treatment for 10 min with ice-cold isotonic NI-hCl solution (155 mM NI-hCI, 10 mM KHCO3, 0.1 mM EDTA, pH 7.4). Granulocytes were resuspended in incubation medium. Purity of the granulocytes was >98% (>95% neutrophils).
J~Chroraium Labeling of Neutrophils
Freshly purified neutrophils were radiolabeled with 51Cr according to Gallin et al. (1973) . Briefly, neutrophils (107 ceUs/ml) were incubated with 1 #Ci 51Cr/106 ceils (sodium chromate, 200-500 Ci/g; New England Nuclear, Boston, MA) in incubation medium (containing 0.1% HSA instead of 0.5% HSA) at 37~ for 1 h under gently shaking conditions and were subsequently washed. Viability after labeling was >95 %.
Endothelial Cell Culture
EC were cultured following standard procedures essentially as described before (Kuijpers et al., , 1992b . In short, EC were isolated from human umbilical cord veins according to Jaffe et al. (1973) with minor modifications (Willems et al., 1982) . Cells were first cultured in plastic flasks (80 cm 2) precoated with fibronectin. The culture medium consisted of an equal mixture of RPMI-1640 and Medium 199, supplemented with 20% (vol/vol) heat-inactivated human serum, penicillin (100 U/ml; Gibco Laboratories), streptomycin (100 t~g/ml; Gibco Laboratories), fungizone (2.5 t*g/mi; Gibco Laboratories), and glutamine (2 mM). After one or two passages with trypsin/EDTA (Gibco Laboratories), EC were subcultured to confluent monolayers on tissue culture-treated polycarbonate membranes (8.0-txm pore size; 24-mm diana) of Transwell cell culture chamber inserts (Costar Data Packaging, Cambridge, MA).
Transfected Cell Lines
HeLa cells stably transfected with CEA (HeLa-CEA), NCA-95 (HeLa-CGM6), NCA-90 (HeLa-NCA), or-as a control-the plasmid only (HeLaNee) have been described before by Berling et al, (1990) . The murine pre-B cells (pMRB101) and the ELAM-l-transfected pre-B cells (pMRB107) were kindly provided by M. Robinson (Cell Tech Ltd., Slough, Berkshire, UK) and have been successfully used before (Leeuwenberg et al., 1992) .
Adherence and Migration Assay
The confluent monolayers were washed twice with basal incubation medium prewanned to 370C. Prewarmed incubation medium with or without an optimal amount of the chemoattractant FMLP (10 nM) was added to the lower chambers (Kuijpers et al., 1992b) . SlCr-labeled neutrophils (106 cells/ rrd)-prewarmed for 10 min at 37~ added to the upper compartments. In some experiments, the neutrophils or the monolayer of endothelial cells were preiacuhated with purified mAb at 20 #g/mi for 10 min before addition of the neutmphils to the upper chamber and remained present during the assay.
The chamber plates were then incubated at 37~ in a 5% CO2 incubator for 30 rain (or other times as indicat~xl). After 30 min, neutrophil fractions were collected, and diluted with a fixed amount of incubation medium that had been used to wash the upper or lower chambers. Radioactivity was determined in three cell fractions: "luminal" (i.e., the content of the upper compartment with a fixed volume of washing buffer), '~abluminal ~ (i.e., the content of the lower compartment plus a fixed volume of buffer used to rinse the basal side of the membrane), and "adhering cell ~ fraction (i.e., the complete membrane, carefully cut out of its container). Recovery was >92%. Adhesion was measured as radioactivity found in the "membrane fraction," and migration was measured as radioactivity found in the abluminal fraction (lower compartment). The results were expressed as percentage of radioactivity added to the chambers.
EC monolayers were pretreated with optimal concentrations of human recombinant IL-1-/~ (rlL-1-/~) (10 U/rnl) or TNF-tx (50 ng/ml). The cytokine was left for 4 h with the ceils, followed by extensive washing of the monolayer with prewarmed incubation medium before use. Under these conditions, no chemoattractant was added to the lower chamber. The "spontaneous" transmigration is driven by EC-derived platelet-activating factor and IL-8, as described elsewhere (Kuijpers et al., 1992a) . rlL-1-B was a gift of Dr. P. T. Lomedico (Hoffmann-La Roche, Nutley, NJ). Human recombinant TNF-ct (rTNF-c~) was a gift of Dr. A. Creasy (Cetus, Oakland, CA).
Immunoprecipitation and Western Blotting
Lysis of 12SI-labeled nentrophils was performed in Hepes medium containing 1% NP-40 (vol/vol), protease inhibitors PMSF (1 raM), N~-p-tosyl-Llysine-chloromethyl ketone (1 mM), leupeptin (20/~g/ml), soybean trypsin inhibitor (20 tLg/ml) (Sigma Chem. Co.), and EDTA (5 mM). After an overnight preclearing step with protein A-Sepharose, immunoprecipitation was performed with the rabbit anti-CEA antiserum, or the murine mAb CLBgranl0 chemically cross-linked to protein A-Sepharose by dimethyl pimelidate, or CLB-B13.9 (Tetteroo et al., 1986) coupled to goat anti-mouse Ig on cyanogen bromide-activated Sepharose. Sham precipitates were performed with CLB-CD2 mAb coupled to protein A-Sepharose. Samples were run with reduced 5-15 % gradient SDS-PAGE together with prestained markers from GIBCO-BRL Life Technologies (Breda, The Netherlands). For autoradiography of the ~25I-labeled immunoprecipitates, X-AR5 film (Eastman Kodak Co., Rochester, NY) was used in combination with intensifier screen (Cronex Lighting Plus, Du Pont Co., Newtown, CT). In experiments with nonradiolabeled neutrophils, cell lysates or immunoprecipirates were (subsequent to 5-15 % reduced SDS-PAGE) electrophoretically transferred to nitrocellulose sheets at 4~ according to standard procedures. After the initial blocking of nitrocellulose with BSA (1% [wt/voll in 10 mM Tris-HC1, 150 mM NaC1, 0.05% Tween 20, pH 8.0), the sheets were incubated with primary antibody at "~10/~g/ml for 1 h. After extensive washes with the Tris/Tween buffer, the alkaline phosphatase-conjugated antimouse Ig antibody (Promega Corp., Madison, WI) was used in the final incubation step for the subsequent enzymatic detection of electroblotted proteins recognized by the primary antibody.
Immunoprecipitation of 125I-radiolabeled or immunoblotting of nonlabeled purified CEA was performed in the same way as described for neutrophil lysates. After immunoprecipitation of the CEA product with CSLEX-1 or CLB-B4.3 (coupled to cyanogen bromide-activated Sepharose), the precipitates were washed and resuspended in a 0.3-M glycine buffer, pH 11, for 1 h. After removal of the Sepharose beads, the soluble fraction was neutralized to pH 7.0 and reprecipitated with CLB-granl0 (IH4).
Results
Inhibition of Neutrophil Adhesion to IL-treated EC
The enhanced neutrophil adherence to cytokine-treated EC can be attributed to a large extent to the expression of ELAM-1, but migration completely depends on functional CD18 (Smith et al., 1988; Luscinskas et al., 1989; Hakkert et al., 1991) . A series of anti-NCA mAbs-directed to common, shared, or specific epitopes (Table I )-was tested for its effect on these processes. Inhibition was found with some mAbs, of which 49.30 most potently interfered with the neutrophil adherence to EC pretreated with rlL-1-/3 (Fig. 1) or TNF-ct (not shown). Under these conditions, neutrophil transmigration was not significantly affected with any of the mAbs tested. Inhibition of adherence by 49.30 (directed to NCA-160 and NCA-90) was maximal when EC were shortly pretreated with cytokines (rlL-1-/~ or TNF-o~ for 4-8 h) to induce an optimal expression of ELAM-1. mAb 49.30 could not be evaluated when the EC monolayers had been pretreated for 24 h with rlL-1-/~ or rTNF-ct, because neutrophil adherence and transmigration were almost absent at that time. Neutrophil adherence and migration across monolayers of resting EC along a gradient of FMLP were unaffected by 49.30 (not shown).
When rnAb 49.30 was used in combination with CD18 or anti-ELAM-1, additive inhibition was only observed with CD18 (Fig. 2) . The inhibition of neutrophil adherence by anti-ELAM-1 mAb was high, because binding of neutrophils to ELAM-1 results in activation of the adhesive CD18 proteins (Lo et al., 1991) . Consequently, the anti-ELAM-1 mAb inhibits neutrophil adherence more efficiently than CD18 . To study the ELAM-l-dependent binding only, the neutrophils were ATP depleted by sodium iodoacetate before use . As shown in Fig. 3 , rnAb 49.30 significantly inhibited the neutrophil adherence also under these conditions. Migration of ATP-depleted neutrophils was absent, either across cytokine-treated EC (Fig. 3) or along a gradient of FMLP (not shown). (Berling et al., 1990) . Control transfected HeLa cells have been designated HeLa-Neo. Surface staining of HeLa cells and purified neutrophils was measured by cytometry on a FACScan (Becton and Dickinson Immanocytometry Sys., Mountain View, CA), essentially as described before (Berling et al., 1990; Kuijpers et al., 1991) . Mean fluorescence intensity + SEM of three to seven experiments. The procedures for immunoblotting of neutrophil lysates are described in Materials and Methods. ~: Nonblotting mAb; antigen has been characterized by immunoprecipitation (Materials and Methods). 
Adhesion of Neutrophils from PNH Patients to IL-treated EC
The NCA-95 and NCA-90 antigens are membrane attached through a lipid PI anchor. Neutrophils of PNH patients are deficient in the expression of these proteins, including the NCA-90 and NCA-95 antigens (Grunert et al., 1990 ; Van der Schoot, C. E., T. W. Kuijpers, G. Nagel, E Grunert, M. Daams, and A. E. G. Kr. von dem Borne, manuscript submitred for publication). Moreover, the amino acid sequence deduced from the cDNA CGM6 (Berling et al., 1990) and NCA (Thompson et al., 1987; Neumaier et al., 1988; Oikawa et al., 1987 )-representing NCA-95 and NCA-90, respectively-had already suggested PI-anchored surface molecules. Two mAbs (MUS and N1), which selectively recognized NCA-90 mAb without binding to NCA-160 or NCA-95 (Table I) , were noted to have a significant inhibiting effect on neutrophil adherence (Fig. 1) . Therefore, PNH neutrophils which completely missed the expression of several PIlinked surface antigens tested but expressed transmembrane molecules at a normal level (Table II) , were studied to further discriminate between the role of NCA-160 versus NCA-90 in adherence and in the inhibition found with 49.30. These PNH neutrophils bound significantly less to rlL-1-#-pretreated EC than did normal control neutrophils. Moreover, NCA-90-deficient neutrophils were still sensitive to inhibition of 49.30 (Fig. 4) , whereas MUS and N1 were without effect (not shown). Together, the results obtained with mAb 4/3/17, N1, and MUS (Table I, Fig. 1 ) and the subsequent observations made with PNH neutrophils are in keeping with a role for NCA-160 as well as NCA-90 in neutrophil adherence to cytokine-treated EC.
Adhesion of LAM-l-negative Neutrophils to IL-treated EC
Whereas the expression of NCA-160, NCA-95, and NCA-90 Figure 4 . Comparison of adherence to rlL-1-/3-pretreated EC between normal control neutrophils and PNH neutrophils deficient in PI-linked antigens such as NCA95/90. Mean + SEM of three experiments. Bars marked by an asterisk display a significant effect (p < 0.05) as compared to the respective neutrophil adherence to IL-l-pretreated EC.
is upregulated during neutrophil activation (Tetteroo et al., 1986 ; Van der Schoot, C. E., T. W. Kuijpers, G. Nagel, E Grunert, M. Daams, and A. E. G. Kr. von dem Borne, unpublished observations), LAM-1 is known to be rapidly shed from the plasma membrane (Jutila et al., 1990; Kishimoto et al., 1991; Kuijpers et al., 1992b) . Under normal conditions, all neutrophils added to the upper compartment express LAMA, as we have described before (Kuijpers et al., 1992a,b) . After pretreatment of neutrophils for 30 min at 37~ with 10 nM FMLP, the neutrophils have become LAM-l-negative, nonaggregated cells . However, the adherence of these neutrophils to rIL-1-/3-activated EC was neither downmodulated, nor inhibited to a significantly larger extent by mAb 49.30 (Table III) .
Inhibition of Adherence by Soluble CEA(-related) Antigen
A soluble CEA product was purchased and tested to substantiate our findings with anfi-NCA mAbs with respect to neutrophil adherence. Neutrophil adherence to cytokine-treated EC, but not to resting EC in the presence of FMLP, was significantly inhibited by soluble CEA(-related) proteins (Fig. 5 A) . Transmigration induced by FMLP or IL-1 pretreatment was not affected by the CEA product. After t25I-labeling, the product was noted to contain two major bands of ,~180 and 150 kD and minor bands of ~100 and 50 kD (Fig. 6) . The high molecular band of 180 kD was immunoblotted with monospecific noncross-reacting anti-CEA mAb 26/3/13. The exact nature of the 150-kD band is as yet unknown. It may be a CEA glycoform also known as CEA-160 (Grunert et al., 1985) (differently glycosylated and thus masking the 26/3/13 epitope), or it may be a large cleavage product of CEA (having lost the 26/3/13 epitope). Alternatively, the 150-kD product may also represent a soluble NCA variant; both the 180 and 150 kD bands were immunoblotted by CLB-granl0 and 49.30 (data not shown). The smaller band of *100 kD was precipitated with B13.9 and is probably the myeloid NCA-95 protein. The low molecular mass band of ~50 kD was blotted by the polyclonal anti-CEA antisernm but not by CLB-granl0 or 49.30. This band most likely represents NCA-50 (Thompson et al., 1987; Barnett and Zimmerman, 1990) . When the CEA product was precleared by CLB-granl0 before testing, no inhibition of neutrophil adherence to rIL-1-~-pretreated EC was observed anymore, whereas the CEA product precleared with CD9 mAb still inhibited neutrophil adherence to these ELAM-l-expressing EC (Fig. 5 B) . Moreover, direct interaction of the CEA product with ELAM-1 was indicated by time course considerations and substantiated by the significant inhibition by anti-ELAM-1 mAb (Fig. 7 A) , as well as the direct interaction of ELAM-1-transfected murine pre-B cells to the CEA product coated on polystyrene (Fig. 7 B) . Anti-ELAM-1 as well as 49.30 mAbs blocked the binding for >85 % (not shown).
Oligosaccharides SLex and Le 9 Present on CEA(-related) Antigens
Sialidase-treated neutrophils have previously been found to lack ELAM-1 binding. Subsequently, the crucial oligosaccharide for ELAM-1 binding was found to be SLe x (Lowe et al., 1990; Goelz et al., 1990; Phillips et al., 1990; Walz et al., 1990; PoUey et al., 1991) . CEA(-related) antigens are well-documented glycoproteins of which oligosaccharide chains constitute 30-50% of the relative molecular weight (Kobata et al,, 1989; Thompson et al., 1991) . CEA contains mainly type II polylactosamine ,) side chains (in contrast to the type I Galfll-3GlcNAc isomers) (Chandrasekaran et al., 1983; Yamashita et al., 1987) -just like most glycoproteins on granulocytes Fukuda et al., 1984 Fukuda et al., , 1986 . These chains bear fucose and sialic acid residues at positions potentially critical for Le ~ and its sialylated form in >50% of its oligosaccharide structure (Chandrasekaran et al., 1983) . Both the NCA-160 and NCA-90 were immunoblotted by the anti-SLe ~ mAb CSLEX-1. NCA-160 was also positively stained in Western blot with anti-Le x rnAb CLB-B4.3 (Fig.  8) , as was shown before by Stocks et al. (1990) . In some experiments, NCA-95 was immunoblotted with anti-Le x as well (not shown). The soluble CEA product was found to be positive for SLe ~ and Le ~ determinants in an ELISA (not shown). Immunoprecipitation with anti-SLe ~ mAb CSLEX-1 or anti-Le x mAb CLB-B4.3 demonstrated that both the 180-and 150-kD bands were SLe x positive. The CEA band of 180 kD was not fully oe-2,3 sialylated at the Le x determinants, as indicated by the immunoprecipitation of the high molecular weight band also with anti-Le x (Fig. 9 A) . As already indicated by the difference in mobility of the high molecular weight bands of CEA in Fig. 9 A, the level of sialylation directly influenced electrophoretic mobility: sialidase treatment of the CEA product induced an apparent increase in the 180 and 150 kD (SLex-positive) bands of ,,o10 kD (Fig. 9 B) . Both the SLe x-and Lex-positive 180-kD band were recognized by the monospecific anti-CEA mAb 26/3/13 (not shown).
When the CEA product was sialidase treated before use, there was no inhibition of neutrophil adherence to rIL-1-/3-pretreated EC to be seen anymore. This was not caused by trace amounts of sialidase, because sialidase-treated HSA did not show any effect (Fig. 5 C) .
D i s c u s s i o n
The function of ELAM-1 as an important adhesion molecule on inflamed endothelium in neutrophil binding in vitro (Bevilacqua et al., 1987; Luscinskas et al., 1989; Kuijpers et al., 1991) has been further substantiated by recent in vivo animal models, in which neutrophil binding and influx were blocked by anti-ELAM-1 mAb (Mulligan et al., 1991; Gundel et al., 1991) .
The SLe x moieties located on glycoproteins have been shown to be essential for neutrophils to bind to ELAM-1 (Lowe et al., 1990; Goelz et al., 1990; Phillips et al., 1990; Walz et al., 1990; Policy et al., 1991) . However, many, surface-expressed (and soluble) glycoproteins may bear the SLe x oligosaccharide. Therefore, SLe x positivity alone cannot be considered as proof for involvement in ELAM-1 binding. Previously, LAM-1 on neutrophils was suggested to be a predominant SLex-bearing ligand for ELAM-1, though not the only one (Picker et al., 1991) .
Of a series of anti-NCA n~b s (Table I) , some were found to significantly inhibit neutrophil adherence to cytokineactivated monolayers of EC, whereas others did not (Fig.  1) . The anti-NCA-160/NCA-90 mAb 49.30 was most effective, but only under conditions of neutrophil adherence to ELAM-l-expressing EC (Fig. 1) . Adherence ofPNH neutrophils (lacking NCA-95 and NCA-90 [ Table II ]) to cytokinetreated EC was sensitive to CD66 mAb 49.30 inhibition, but to a very limited extent (Fig. 4) . Together with the data obtained with the more selective anti-NCA mAbs 4/3/17, N1, and MUS (Table I, Fig. 1 ), this indicates that NCA-90 and to some extent NCA-160 are involved in adherence. We did not find any inhibitory effect with the CD67 mAbs.
Glycosylation of the CEA/NCA molecules is essential. First, HeLa cells transfected with CEA (HeLa-CEA), NCA-95 (HeLa-CGM6), or NCA-90 (HeLa-NCA) did not consistently bind to ELAM-l-expressing EC. Le x or SLe X determinants were absent on the HeLa cells-transfected or n o t -(data not shown), which is in keeping with the fact that HeLa cells do not have any ~1,3 fucosyl transferase activity (Goelz et al., 1990) . Second, the soluble CEA product lost all inhibitory capacity upon sialidase treatment (Fig. 5 C) .
Although transfection studies of Oikawa et al. (1989) and Benchimol et al. (1989) have demonstrated that aggregation of CEA/NCA-transfected COS cells can occur, neutrophils (or CEA/NCA-transfected HeLa cells) continuously and stably expressing these molecules do not spontaneously form clusters. The NCA proteins on neutrophils have evolved to presenter molecules of the correct oligosaccharide determinants for lectin-like molecules such as ELAM-1 (Bevilacqua et al., 1989) . Binding of CEA(-related) antigens to ELAM-1 was evidenced, as shown in Fig. 7 , A and B.
Our data strongly indicate that, apart from LAM-1 and the NCA proteins, other SLex-beadng presenter molecules also contribute to the adherence of neutrophils to ELAM-I-expressing EC. First, LAMA-negative neutrophils are still able to bind to cytokine-treated, ELAM-l-expressing EC (Table III) . This finding corroborates a role for LAMA especially in the initial phase of neutrophil adherence to cytokine-treated EC . This notion is in line with the adhesion studies at 500 s by Smith et al. (1991) and Kishimoto et al. (1991) . Second, the inhibition of neutrophil adherence by CD66 mAb 49.30 was not dramatically increased upon prior LAM-1 shedding (Table ~I) . Third, anti-ELAM-1 mAb consistently showed a stronger inhibition of neutrophil adherence to cytokine-treated EC than did 49.30 (Fig. 2) .
We have found that the surface-expressed NCA molecules on neutrophils can trigger CD18 activation, hence contribut- ing to a strengthening of neutrophil adherence to EC via CD18-dependent binding. This NCA-mediated triggering is absent in PNH neutrophils (Kuijpers, T. W., C. E. Van der Schoot, M. Hoogerwerf, and D. Roos, manuscript submitted for publication). Thus, both NCA-160 and NCA-90 are involved in neutrophil adherence but only NCA-90 seems to increase adherence via CD18 activation. We and others (Lo et al., 1991) 
